{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:19:23Z","timestamp":1791904763764,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126542","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T07:50:24Z","timestamp":1732866624000},"page":"126542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial"],"prefix":"10.1016","volume":"44","author":[{"given":"Vu Dinh","family":"Thiem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Duc","family":"Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Hai","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Van Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Cong","family":"Thang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Mateus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Raghunandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Mai","family":"Huong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laina D.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Alexandar","family":"Escarrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong Huu","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Van Be","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Weiskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126542_bb0005","doi-asserted-by":"crossref","first-page":"1087138","DOI":"10.3389\/fpubh.2022.1087138","article-title":"The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries","volume":"10","author":"Duroseau","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2024.126542_bb0010","author":"Ministry of Health portal. COVID-19 epidemic prevention bulletin dated 3\/1 of the Ministry of Health. Ministry of Health [Internet]"},{"key":"10.1016\/j.vaccine.2024.126542_bb0015","first-page":"1","article-title":"WHO releases global COVID-19 vaccination strategy update to reach unprotected","author":"World Health Organization","year":"2022","journal-title":"World Health Organiz [Internet]"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126542_bb0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"6576","key":"10.1016\/j.vaccine.2024.126542_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126542_bb0030","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from alpha to omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126542_bb0035","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1038\/s41467-021-26499-y","article-title":"A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses","volume":"12","author":"Sun","year":"2021","journal-title":"Nat Commun"},{"issue":"26","key":"10.1016\/j.vaccine.2024.126542_bb0040","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1016\/j.vaccine.2022.04.078","article-title":"Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: interim results of a randomized, placebo-controlled, phase 1\/2 trial in Vietnam","volume":"40","author":"Duc Dang","year":"2022","journal-title":"Vaccine"},{"issue":"10269","key":"10.1016\/j.vaccine.2024.126542_bb0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126542_bb0050","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/s41596-021-00536-y","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays","volume":"16","author":"Bewley","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2024.126542_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103626","article-title":"Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients","volume":"73","author":"Carre\u00f1o","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126542_bb0060","doi-asserted-by":"crossref","first-page":"994","DOI":"10.4049\/jimmunol.1600320","article-title":"Cytokine-independent detection of antigen-specific germinal center T follicular helper cells in immunized nonhuman Primates using a live cell activation-induced marker technique","volume":"197","author":"Havenar-Daughton","year":"2016","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126542_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186998","article-title":"Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells","volume":"12","author":"Reiss","year":"2017","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.vaccine.2024.126542_bb0070","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126542_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/00034983.1986.11812071","article-title":"Efflux of 3H-thymidine by erythrocytes from mice infected with Trypanosoma brucei brucei","volume":"80","author":"Ogbunude","year":"1986","journal-title":"Ann Trop Med Parasitol"},{"issue":"6529","key":"10.1016\/j.vaccine.2024.126542_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"issue":"6566","key":"10.1016\/j.vaccine.2024.126542_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126542_bb0090","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"683","key":"10.1016\/j.vaccine.2024.126542_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2847","article-title":"An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination","volume":"15","author":"Carre\u00f1o","year":"2023","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126542_bb0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.vaccine.2021.12.006","article-title":"Towards a population-based threshold of protection for COVID-19 vaccines","volume":"40","author":"Goldblatt","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126542_bb0105","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2024.126542_bb0110","author":"Biological E. Limited"},{"key":"10.1016\/j.vaccine.2024.126542_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.crimmu.2022.08.005","article-title":"From alpha to omicron: the response of T cells","volume":"3","author":"Grifoni","year":"2022","journal-title":"Current Res Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126542_bb0120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/pathogens12070862","article-title":"The importance of measuring SARS-CoV-2-specific T-cell responses in an ongoing pandemic","volume":"12","author":"Petrone","year":"2023","journal-title":"Pathogens"},{"issue":"10277","key":"10.1016\/j.vaccine.2024.126542_bb0125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126542_bb0130","author":"United Kingdom Department of Health and Social Care"},{"issue":"14","key":"10.1016\/j.vaccine.2024.126542_bb0135","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:47:32Z","timestamp":1735656452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"alternative-id":["S0264410X24012246"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126542","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.30.23299208","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126542"}}